White House Releases Advisories on Fentanyl Trafficking
The White House, via the Office of National Drug Control Policy (ONDCP), released a series of advisories aimed to curb international and domestic fentanyl trafficking. According to the report summary, “private sector businesses’ platforms are vulnerable to being exploited by Drug Trafficking Organizations (DTOs) in their production, trafficking, and distribution of fentanyl and other synthetic opioids.” Consequently, the primary goal of this multi-agency effort is to increase information sharing with businesses that are potentially exposed to trafficking of illicit fentanyl or other synthetic opioids.
In particular, each advisory covers four unique stages of illicit drugs trafficking:
- Manufacturing: Aims to broaden the public and private sectors awareness of various stages of illicit fentanyl manufacturing and distribution;
- Marketing: Provides information for digital private sector partners about marketing and sale tactics of illicit fentanyl via social media, online forums, and e-commerce platforms;
- Movement: Identifies methods of intercepting illicit transportation of fentanyl and other illicit synthetic opioids;
- Money: Focuses on financial institutions and their role in detecting and reporting illicit financial schemes aimed to disguise opioid trafficking activities.
Significantly, each advisory underscores the importance of public-private collaboration in combatting opioid epidemic in America. Furthermore, given the extent of the opioid crisis, this series expands upon the Federal government’s response to the 21st century drug threat. As such, the current polices include the 2019 National Drug Control Strategy and the President Trump’s Initiative to Stop Opioid Abuse and Reduce Drug Supply and Demand. In combination, these efforts highlight the urgent need for a shared public-private action framework to reduce the number of lives lost to synthetic opioids.
The HSDL offers many additional resources related to the opioid crisis in our special featured topic Opioids, and in our series National Drug Threat Assessment. Please note: you might need a HSDL login to view some of these resources.
Need help finding something? Ask one of our librarians for assistance!